| Bioactivity | α-Amylase/α-Glucosidase-IN-7 (Compound 3f) is a competitive α-glucosidase and α-amylase enzyme inhibitor with IC50 values of 18.52 and 20.25 µM, respectively. α-Amylase/α-Glucosidase-IN-7 can also effectively inhibit AChE and BChE, with IC50 values of 9.25 and 10.06 µM respectively. α-Amylase/α-Glucosidase-IN-7 can be used in diabetes and Alzheimer’s research[1]. |
| Name | α-Amylase/α-Glucosidase-IN-7 |
| CAS | 1038094-94-8 |
| Formula | C15H9Cl2FN2OS |
| Molar Mass | 355.21 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Fatima B, et al. Multitargeted inhibition of key enzymes associated with diabetes and Alzheimer's disease by 1,3,4-oxadiazole derivatives: Synthesis, in vitro screening, and computational studies. Arch Pharm (Weinheim). 2023 Dec;356(12):e2300384. |
α-Amylase/α-Glucosidase-IN-7
CAS: 1038094-94-8 F: C15H9Cl2FN2OS W: 355.21
α-Amylase/α-Glucosidase-IN-7 (Compound 3f) is a competitive α-glucosidase and α-amylase enzyme inhibitor with IC50 v
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.